The FDA issued warning letters to multiple telehealth providers regarding marketing claims about compounded products
Tirzepatide, sold as Mounjaro, has already been approved for treating Type 2 diabetes since May 2022, but now, patients can be prescribed the drug for chronic weight management
Reduces the appearance of dark spots and hyperpigmentation
When it is finally released, its availability must be more strictly controlled than semaglutide to avoid similar life-threatening usage. Dr Marie Spreckley, of the MRC epidemiology unit at the University of Cambridge, said: Higher discontinuation due to adverse events, particularly gastrointestinal symptoms, is a key consideration and may have implications for tolerability and adherence in real-world settings. She added that because the trial lasted only one year, longer-term safety, cardiovascular outcomes and sustained effectiveness remained important unanswered questions
Ghrelin strengthens gastric emptying and stimulates contractile activity in the GI tract (122)
Hair follicles are some of the fastest-dividing cells in your body, so theyre among the first to suffer when nutrient supplies dwindle
